On November 2, 2022 Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated cancers, reported that company leadership is scheduled to present and participate in one-on-one meetings at four investor conferences in November (Press release, Viracta Therapeutics, NOV 2, 2022, View Source [SID1234622801]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel 2022 Healthcare Conference (in-person)

13th Annual Jefferies London Healthcare Conference (in-person)

Piper Sandler 34th Annual Healthcare Conference (in-person)

5th Annual Evercore ISI HealthCONx Conference (virtual)

A live webcast of each presentation will be available on the Investors section of the Viracta website under "Events and Webcasts" at View Source The webcasts will be archived for at least 30 days following the presentation.